CARGO Therapeutics (CRGX) Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Zymeworks (NASDAQ:ZYME) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Which has more volatility and risk, CRGX or ZYME?

CARGO Therapeutics has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Zymeworks has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Do institutionals and insiders have more ownership in CRGX or ZYME?

93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 92.9% of Zymeworks shares are held by institutional investors. 2.9% of CARGO Therapeutics shares are held by company insiders. Comparatively, 1.9% of Zymeworks shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Do analysts prefer CRGX or ZYME?

CARGO Therapeutics presently has a consensus price target of $15.40, suggesting a potential upside of 240.71%. Given CARGO Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe CARGO Therapeutics is more favorable than Zymeworks.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CARGO Therapeutics	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Zymeworks	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is CRGX or ZYME more profitable?

CARGO Therapeutics has a net margin of 0.00% compared to Zymeworks' net margin of -59.96%. Zymeworks' return on equity of -21.59% beat CARGO Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CARGO Therapeutics	N/A	-43.21%	-37.26%
Zymeworks	-59.96%	-21.59%	-16.52%

Which has higher earnings & valuation, CRGX or ZYME?

Zymeworks has higher revenue and earnings than CARGO Therapeutics. Zymeworks is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CARGO Therapeutics	N/A	N/A	-$167.50M	-$4.64	-0.97
Zymeworks	$122.87M	8.63	-$122.69M	-$0.97	-14.54

Does the media refer more to CRGX or ZYME?

In the previous week, Zymeworks had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 5 mentions for Zymeworks and 3 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.93 beat Zymeworks' score of 0.30 indicating that CARGO Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CARGO Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zymeworks	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CARGO Therapeutics and Zymeworks tied by winning 7 of the 14 factors compared between the two stocks.